THE AML HUB INCREASES CONGRESS COVERAGE TO PROVIDE LATEST DEVELOPMENTS IN ACUTE MYELOID LEUKEMIA TREATMENT AND RESEARCH

LYMPHOMA HUB MAINTAINS ITS FOCUS ON RAISING THE LEVELS OF GLOBAL KNOWLEDGE OF LYMPHOMA IN 2022


THE MPN HUB CONTINUES TO PROVIDE THE LATEST TREATMENT AND RESEARCH UPDATES IN THE FIELD OF MYELOPROLIFERATIVE NEOPLASMS


THE GvHD HUB IN Q1 2022: BOOSTING LEVELS OF KNOWLEDGE IN THE GRAFT-VERSUS-HOST DISEASE SETTING THROUGH KEY UPDATES AND CONGRESS COVERAGE


NTT Announces Global Availability of New Managed Campus Networks Services Enhancements


Multiple Myeloma Hub continues to enhance global knowledge of myeloma throughout 2022